Table 3.
Summary of drug-related adverse events.
| Drug-related AEs occurring in > 10% of patients, N (%) | Age group |
Total (n = 65) | ||||
|---|---|---|---|---|---|---|
| <1 year (n = 11) | 1 to < 2 years (n = 11) | 2 to < 4 years (n= 23) | 4 to < 7 years (n = 20) | |||
|
| ||||||
| Upper respiratory tract infection | 3 (27.3%) | 2 (18.2%) | 3 (13.0%) | 4 (20.0%) | 12 (18.5%) | |
| Abdominal pain | 2 (18.2%) | 0 | 6 (26.1%) | 2 (10.0%) | 10 (15.4%) | |
| Vomiting | 2 (18.2%) | 3 (27.3%) | 4 (17.4%) | 1 (5.0%) | 10 (15.4%) | |
| Diarrhea | 1 (9.1%) | 1 (9.1%) | 4 (17.4%) | 2 (10.0%) | 8 (12.3%) | |
|
| ||||||
| Drug-related SAEs, N (%) | Age group |
Total (n = 65) | ||||
| <1 year (n = 11) | 1 to < 2 years(n= 11) | 2 to < 4 years (n = 23) | 4 to < 7 years (n = 20) | |||
|
| ||||||
| Colitis ulcerative | 0 | 0 | 0 | 1 (5.0%) | 1 (1.5%) | |
| Diarrhea | 0 | 0 | 0 | 1 (5.0%) | 1 (1.5%) | |
| Convulsion | 0 | 0 | 1 (4.3%) | 0 | 1 (1.5%) | |
AE: adverse event; N: number of patients; SAE: serious adverse events.